• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Norway

dkNET community events and announcements in October, 2020

  • 03:54pm October 13, 2020
  • Ko-Wei Lin

Dear dkNET Community,

dkNET provides updates on activities of interest to the NIDDK-supported community. You could keep up to date on these activities through our Twitter feed @dkNET_info, through our Community Calendar, or through dkNET e-mail list. If you have an event or funding opportunities you'd like to advertise, please contact us info_at_dknet.org.


dkNET News

  • dkNET Webinar Series We are excited to announce the launch of our next dkNET Webinar Series. In October, we will have two webinars: ""Creating And Sustaining A FAIR Biomedical Data Ecosystem," presented by Dr. Susan Gregurick, Associate Director of Data Science and Director, Office of Data Science Strategy at the National Institutes of Health on Friday, Oct. 9, 2020, 11 am - 12 pm PDT, and "Pharos/Illuminating Druggable Genome (IDG)", presented by Dr. Tudor Oprea on Friday, Oct. 23, 2020. Check out all upcoming webinar schedule at https://dknet.org/about/webinar
  • Beta Testers Wanted dkNET is planning to develop a new dkNET service called Resource Watch - a tool to allow scientists to report an issue/validation information of a resource such as cell lines and antibodies. We are looking for scientists who might be interested in doing an online prototype test (10 -15 minutes) and giving us feedback to improve the prototype. If you are interested, please contact Dr. Ko-Wei Lin (koweilin@ucsd.edu).
  • New Publication Congratulations to Dr. Chun-Nan Hsu and co-authors from the dkNET team, RRID team, FAIR Data Informatics Lab at the University of California San Diego, and collaborators at National Central University in Taiwan on publishing a new preprint "Antibody Watch: Text Mining Antibody Specificity from the Literature"! Download the preprint at https://arxiv.org/abs/2008.01937
  • RRID News Research Resource Identifiers (RRID) mentioned in the Article "When antibodies mislead: the quest for validation" published in Nature Technology Features! The article, written by Monya Baker, mentioned the importance of including RRIDs for antibodies in research articles. RRIDs can help identify antibodies used! RRID project is led by Dr. Anita Bandrowski and collaborated with dkNET, SciCrunch, and Neuroscience Information Framework. Based on the RRID infrastructure, dkNET develops tools and services such as Resource Reports and Authentication Reports. Resource Reports allow researchers to track the resource information and performance, to help researchers to select a resource. Authentication Reports assist researchers in the preparation of authentication plans when submitting NIH grants!
  • New Resources added to dkNET
    • T2DSystems (RRID:SCR_018913) is a project to bridge gap between in vitro human islet studies and clinical studies in human subjects. It is used to integrate cellular and medical research data, collected by partners, with computational modeling to identify pathophysiological mechanisms and markers of spectrum of biological and cellular processes involved in pancreatic beta cell failure leading to impaired glucose tolerance and T2D.
    • Diabetic Foot Consortium (RRID:SCR_018914) is a group of academic institutions committed to studying diabetic foot conditions, such as foot ulcers and wound healing, to develop predictive biomarkers which can be later used to create better treatment plans and improve health and quality of life for people living with diabetes.
    • Nephroseq (RRID:SCR_019050) is a web-based gene expression database and analysis platform. It is used for integrative data mining of genotype and phenotype data, with optimized workflows. It is supported by the Applied Systems Biology Core as part of the University of Michigan O'Brien Renal Center. The primary goal of the Applied Systems Biology Core is to provide to the renal research community a platform for integrative data mining of comprehensive renal disease gene expression data sets.
    • mousecovid.org (RRID:SCR_018814) is a portal for Global Mouse Models for COVID-19 consortium. It presents the consortium, its statement and membership, and URLs for mouse COVID-19 resources worldwide.


Events in October, 2020

Oct. 02, 2020

ELM 2020 Bioinformatics for Lipidomics Symposium

The ILS Applied Bioinformatics Interest Group invites you to join the Bioinformatics for Lipidomics Symposium on October 2nd, 2020, as part of this year’s joint virtual European Lipidomics Meeting and Lipidomics Forum. The preliminary schedule is available on the https://elm2020.de/program/ page and below. The symposium will be divided into four major sessions: 1) Databases, Ontologies and Online Resources 2) Visualization and Exploration 3) Data Integration and Applications 4) Identification and Quantification Tools.
More Information: https://lipidomicssociety.org/2020/08/31/elm-2020-bioinformatics-for-lipidomics-symposium/

Oct. 05, 2020

Webinar Series on Sphingolipid Biology : Homeostatic and Pathogenic roles of GM3 ganglioside

Presenter: Jin-ichi Inokuchi
Innate immune signaling via TLR 4 plays critical roles in pathogenesis of metabolic disorders, but the contribution of different lipid species to metabolic disorders and inflammatory diseases is less clear. GM 3 ganglioside in human serum is composed of a variety of fatty acids, including long?chain (LCFA ) and very?long?chain (VLCFA ). Analysis of circulating levels of human serum GM 3 species from patients at different stages of insulin resistance and chronic inflammation reveals that levels of VLCFA ?GM 3 increase significantly in metabolic disorders, while LCFA ?GM 3 serum levels decrease. Specific GM 3 species also correlates with disease symptoms. VLCFA ?GM 3 levels increase in the adipose tissue of obese mice, and this is blocked in TLR 4?mutant mice. In cultured monocytes, GM 3 by itself has no effect on TLR 4 activation; however, VLCFA ?GM 3 synergistically and selectively enhances TLR 4 activation by LPS /HMGB 1, while LCFA ?GM 3 and unsaturated VLCFA ?GM 3 suppresses TLR 4 activation. GM 3 interacts with the extracellular region of TLR 4/MD 2 complex to modulate dimerization/oligomerization. Ligand?molecular docking analysis supports that VLCFA ?GM 3 and LCFA ?GM 3 act as agonist and antagonist of TLR 4 activity, respectively, by differentially binding to the hydrophobic pocket of MD 2. Our findings suggest that VLCFA ?GM 3 is a risk factor for TLR 4?mediated disease progression.
More Information: https://www.sphingolipidbiology.com/inokuchi

Oct. 07, 2020

Advancing Basic and Translational Research for Genitourinary Conditions: Female Urethral Function and Failure Weekly Session 2

Session 2—The Urethra: Current Knowledge of Urethral Function in Health and Disease. Enormous knowledge gaps exist in our understanding of the function and dysfunction of the lower urinary tract. To fill these gaps, we are pioneering a virtual workshop series composed of seven weekly sessions. These sessions will convene a multiperspective brain trust, including basic, translational, and clinical researchers at all stages of their careers; health professionals; patients; and industry representatives.

More information: https://www.niddk.nih.gov/news/meetings-workshops/2020/Advancing-Basic-Translational-Research-Benign-Genitourinary-Conditions-Female-Urethra


Oct. 07, 2020

Abstract Submission Due Date: CELL BIO virtual 2020

The ASCB and EMBO invite the submission of abstracts that report new scientific research developments in the areas of cell biology. Abstracts are welcome from scientists and students in all sectors, including academia, industry, government, and education.
More information: https://www.ascb.org/cellbiovirtual2020/abstracts

Oct. 09, 2020

dkNET Webinar Series: Creating And Sustaining A FAIR Biomedical Data Ecosystem

In this presentation, Susan Gregurick, Ph.D., Associate Director of Data Science and Director, Office of Data Science Strategy at the National Institutes of Health, will share the NIH’s vision for a modernized, integrated FAIR biomedical data ecosystem and the strategic roadmap that NIH is following to achieve this vision. Dr. Gregurick will highlight projects being implemented by team members across the NIH’s 27 institutes and centers and will ways that industry, academia, and other communities can help NIH enable a FAIR data ecosystem. Finally, she will weave in how this strategy is being leveraged to address the COVID-19 pandemic. Presenter: Susan Gregurick, Ph.D., Associate Director of Data Science and Director, Office of Data Science Strategy at the National Institutes of Health.

More information: https://dknet.org/about/blog/2144


Oct. 14, 2020

Advancing Basic and Translational Research for Genitourinary Conditions: Female Urethral Function and Failure Weekly Session 3

Session 3—The Urethra: The Mucosal, Submucosal, and Sensory Aspects
Enormous knowledge gaps exist in our understanding of the function and dysfunction of the lower urinary tract. To fill these gaps, we are pioneering a virtual workshop series composed of seven weekly sessions. These sessions will convene a multiperspective brain trust, including basic, translational, and clinical researchers at all stages of their careers; health professionals; patients; and industry representatives.

More information: https://www.niddk.nih.gov/news/meetings-workshops/2020/Advancing-Basic-Translational-Research-Benign-Genitourinary-Conditions-Female-Urethra


Oct. 14, 2020

Diabetes Research Center Virtual Seminar Series: Behavioral Health Problems and Diabetes: Risk, Prevention, and Management Among Native Peoples

Presented by Spero Manson, PhD (U. Colorado). The Virtual Diabetes Research Center Seminar Series is an effort to connect investigators and trainees during this time of great change and isolation related to the COVID crisis. This seminar series is organized by the NIDDK-funded Diabetes Research Centers at the Albert Einstein College of Medicine, Columbia University, Joslin Diabetes Center, Indiana University, Stanford University, the University of Alabama at Birmingham, UCSD/UCLA, UCSF, the University of Chicago, the University of Colorado, the University of Michigan, the University of Washington, Vanderbilt University, Washington University, Yale University, and in North Carolina (logos and connections below). This seminar series features an outstanding scientist discussing the latest in diabetes, obesity, or metabolic research.
More Information: https://www.vumc.org/diabetescenter/virtual-seminar-series

Oct. 19, 2020

Sphingolipid Biology Webinar: The unique ESCRT-III mechanics that drives membrane remodelling

Description: Presenter: Aurelien Roux
ESCRT-III is the most ancient membrane remodelling machineries as it is the only one present in Archaea, and are thought to be essential for the creation and maintenance of an endomembrane system. As a matter of facts, it is the only machinery that can work on every membrane: ER, endosomes/lysosomes, plasma membrane, but also the autophagosome and pathogen’s vacuoles. In opposition to other machineries such as Cathrin or COPs, ESCRT-III is composed of small subunits all sharing the same biochemical structure, making difficult to apprehend the structure/function link. By reconstituting in vitro ESCRT-III mediated membrane deformation and fission, we will discuss the mechanism by which ESCRT-III is dynamically remodelling membranes. In particular, we will show that sequential assembly of helical filaments with different dimensions, orientations to the membrane and rigidities, drives deformation and then fission. We will then discuss the essential biochemical activities required for this function, and should be common to all species, from Archaea to mammals.

Sphingolipid Biology Webinar: Plasma membranes are asymmetric in lipid unsaturation, packing and protein shape

Presenter: Ilya Levental.
More Information: https://www.sphingolipidbiology.com/event-details/plasma-membranes-are-asymmetric-in-lipid-unsaturation-packing-and-protein-shape

Oct. 21, 2020

Advancing Basic and Translational Research for Genitourinary Conditions: Female Urethral Function and Failure Weekly Session 4

Session 4—The Urethra: Neural Control and Integration. Enormous knowledge gaps exist in our understanding of the function and dysfunction of the lower urinary tract. To fill these gaps, we are pioneering a virtual workshop series composed of seven weekly sessions. These sessions will convene a multiperspective brain trust, including basic, translational, and clinical researchers at all stages of their careers; health professionals; patients; and industry representatives.

More information: https://www.niddk.nih.gov/news/meetings-workshops/2020/Advancing-Basic-Translational-Research-Benign-Genitourinary-Conditions-Female-Urethra


Oct. 21, 2020

Lipid Maps Webinar: A discussion of approaches to interpretation of data from sphingolipidomic analyse

Presented by: Drs. Al Merrill, Yusuf Hunnun, Chiara Luberto.

dkNET Webinar Series: Illuminating Druggable Genome with Pharos

Presenter: Tudor Oprea, MD, PhD, Professor of Medicine, Chief of Translational Informatics Division & Internal Medicine, University of New Mexico.

More information: https://dknet.org/about/webinar



Oct. 25-28, 2020

[Cancelled] Conference :GPCR Signaling Drug Discovery – Modeling from Molecules to Cells

Description: Changes of the microbiome and nutrient sensing within the gut alter whole-body glucose and energy homeostasis. The underlying mechanism and the therapeutic potential of such metabolic regulation in diabetes, obesity, and related disorders remain largely unexplored. This Keystone Symposia conference aims to progressively highlight a spectrum of basic and translational investigations and discoveries that first focus on microbial-host interaction and nutrient sensing mechanisms. Other sessions focus on the interaction between the gut microbiome and nutrient sensing pathways as well as how these pathways could be targeted by small molecules and/or immunological responses within the gut to impact systemic organs and whole-body metabolic homeostasis. In summary, we anticipate this conference will foster interactions between the basic, translational, clinical and pharmaceutical researchers and promote collaborative work aimed at realizing the therapeutic potential of targeting the gut microbiota-nutrient sensing axis for the treatment of metabolic disorders.
More Information: https://www.keystonesymposia.org/KS/Online/Events/2021S8/Details.aspx?EventKey=2021S8


Oct. 31, 2020

Lipid Maps Conference: Spring School Application Deadline

This Spring School will focus on theoretical and practical aspects of lipidomics, using state-of-the-art approaches. There will be a major focus on the underlying biology and biochemistry of lipids, including their roles in health and disease.

More information: https://springschool.lipidmaps.org/


Funding opportunities information and deadlines in October, 2020

Oct. 01, 2020

International Society of Nephrology Funding Opportunity Application Due Date: Fellowship Program

Through the ISN Fellowship Programs, Fellows from Low and Middle Income countries get individual and hands-on training in their selected host institutions. They return home with new skills and knowledge in basic and clinical nephrology, dialysis, transplantation, epidemiology. They improve treatment, teach and train others and become future leaders in the developing world. Over the years, this program has also allowed nephrologists from all over the world to train in host centers in their own regions rather than exclusively in North America, Europe or Australasia.

More information: https://www.theisn.org/fellowship



Oct. 03, 2020

NIDDK Funding Opportunity Letter of Intent Due: New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed)

The New Investigator Gateway Award in T1D Research is designed to ensure that a robust pipeline of talented new investigators will continue to embark on successful careers in T1D research. In addition to providing support for preliminary research, the Gateway program provides an opportunity for new Program Directors/Principal Investigators (PD/PIs) to pursue their studies within the intellectual environment of a select number of large, ongoing collaborative research programs. Embedding awardees within an established scientific framework in each of these consortia will provide unique opportunities for New and Early Stage Investigators to increase their understanding of key questions in the field, to network, and to establish unique and potentially long-lasting collaborations that will propel their careers forward. It is anticipated that the Gateway award will providethe support needed to enhance the success of future R01 submissions from New Investigators interested in pursuing careers in T1D research.

More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-026.html


Oct. 03, 2020

NIDDK Letter of Intent Due: Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of new approaches to create devices/components with enhanced accuracy and less patient burden that will represent real advancements regarding safety and effectiveness of glucose control technologies and their integration into open and closed loop hormone replacement systems.

More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-027.html


Oct. 04, 2020

NIDDK Funding Opportunity Letter of Intent Deadline: George M. O'Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) seeks applications for the George M. O’Brien Urology Cooperative Research Centers Program (U54). This program will foster multi- and interdisciplinary collaboration between basic, translational, and clinical researchers with diverse expertise to address questions of underlying etiology and biological and clinical features of benign genitourinary diseases and disorders within the NIDDK’s mission. In addition, the program will serve as a national resource for the larger urologic research community and provide opportunities for educational enrichment and engagement of investigators in pilot projects that target innovative science and researchers new to urology. All efforts will address the overall goal of improving prevention and clinical management of benign genitourinary disorders through research excellence, enhanced sharing of resources and access to core services, and establishment of a robust research community trained to address the Nation’s biomedical research needs for benign genitourinary diseases and disorders. 

More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-008.html


Oct. 04, 2020

NIDDK Funding Opportunity Letter of Intent Deadline: Caring for Out Patients after Acute Kidney Injury (COPE-AKI)- Clinical Centers (U01 Clinical Trial Required)

Acute kidney injury (AKI) is associated with high morbidity, including increased risk of chronic kidney disease (CKD), end-stage kidney disease (ESKD), cardiovascular disease, and mortality. Severity, duration, and frequency of episodes of AKI as well as age, pre-existing CKD, and other comorbidities are associated with greater risks of CKD progression and death. There is limited evidence to inform recommendations for processes of care or therapeutic interventions targeting progression of kidney disease and the associated morbidity and mortality in AKI survivors. This is a missed opportunity to prevent chronic disease and premature death. The Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Consortium composed of 3 to 4 Clinical Centers (CCs) and a Scientific and Data Research Center (SDRC) will develop and test interventions that aim to reduce morbidity compared with usual care in Stage 2 and 3 AKI survivors. This FOA pertains to the CCs. Application Deadline: November 4, 2020.

More Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-011.html

Oct. 05, 2020

Notice of Special Interest (NOSI) Submission Due Date: Obesity Policy Evaluation Research (R01 Clinical Trial Not Allowed)

The purpose of this Notice is to inform potential applicants of NIH’s interest in research evaluating large-scale policies or programs implemented at the local, state or national level that are expected to influence obesity-related behaviors (e.g., dietary intake, physical activity, or sedentary behavior) and/or weight outcomes with a goal of preventing or reducing rates of obesity.

More Information: https://grants.nih.gov/grants/guide/notice-files/NOT-DK-20-035.html


Oct. 10, 2020

NIDDK Funding Opportunity Letter of Intent Deadline: Chronic Kidney Diseasees of Uncerrtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Renal Science Core (U01- Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites applications for a Renal Science Core (RSC) to support and provide scientific guidance as part of a new consortium to study Chronic Kidney Disease of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE). The RSC will provide scientific expertise in planning clinical phenotyping and measures of renal function; will guide strategies for biological sampling and handling; and will provide needed clinical laboratory based measures and renal pathology. The RSC will also provide renal pathophysiologic expertise to propose approaches, novel measures (e.g., omics and molecular markers) and interpret discovery science to elucidate the cause or causes of CKDu. Application Due Date: November 10, 2020.

More Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-018.html

Oct. 10, 2020

NIDDK Funding Opportunity Letter of Intent Deadline: Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Field Epidemiology Sites (U01 - Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites applications for Field Epidemiology Sites (FES) to enroll research participants in the consortium to study Chronic Kidney Disease of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE). The FES will recruit, enroll and follow participants with evidence of CKDu and appropriate control participants; collect data and conduct clinical assessments; collect biological and environmental samples; and maintain partnerships with local leaders, health care providers, health ministries, or governments. Application Due Date: November 10, 2020.

More Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-017.html

Oct. 10, 2020

NIDDK Funding Opportunity Letter of Intent Deadline: Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Scientific Data Coordinating Center (SDCC) (U24 - Clinical Trial Not Allowed)

This Funding Opportunity Announcement invites applications for a Scientific Data Coordinating Center (SDCC) which will lead a new consortium, Chronic Kidney Disease of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE), in the development and successful execution of study designs and protocols. The SDCC will provide data management and analysis, as well as overall project management for the Consortium. Application Due Date: November 10, 2020.

More Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-019.html


Oct. 16, 2020

NIH Funding Opportunity Application Deadline: Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) is intended to support tool or technology development projects, opening new areas of science or translational research. The projects supported by this FOA could involve proof-of-concept studies, prototyping, optimization of a technology for the unique anatomy or physiology of these organ systems, and refinement of technical specifications for subsequent deployment of the technology in laboratory or clinical settings.

More information: https://grants.nih.gov/grants/guide/pa-files/PAR-20-140.html


Oct. 16, 2020

NIDDK Funding Opportunity Application Deadline: Notice of Specialist Interest (NOSI): Advancing Polycystic Kidney Disease (PKD) Research through Catalytic Tool and Technology Development

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is issuing this Notice of Special Interest (NOSI) to announce the opportunity for investigators to apply for funding for developing novel tools and technologies that enable new lines of scientific inquiry and/or treatment, prevention, or diagnosis of Polycystic Kidney Disease (PKD).

More information: https://grants.nih.gov/grants/guide/notice-files/NOT-DK-20-034.html



Oct. 20, 2020

NIDDK Funding Opportunity Application Due Date: NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites applications that propose a Center for Diabetes Translation Research (CDTR) to advance research along the spectrum of diabetes T2-T4 translational research (i.e., bedside to clinical practice and community settings, dissemination and implementation). The purpose of this Centers program is to accelerate innovation of diabetes translation to maximize positive impacts of research on population health through activities and core services that offer specialized expertise, tools, education, and support. An emphasis on novel methods and research to address health equity and reduce diabetes-related health disparities is encouraged. Novel research cores designed to improve other aspects of person-centered, community, and population health are also encouraged with justification for how such strategies may be adapted to meaningfully inform disparity-reduction approaches. A scientific base reflecting academic institutions and diverse organizational collaborators (e.g., healthcare systems, community organizations, health departments, human services) is expected to foster a Center framework necessary for improving population health. CDTRs are based on the core concept whereby shared resources aimed at fostering productivity, synergy, and novel research ideas among the funded investigators are supported in a cost-effective manner.

More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-002.html



Oct. 21, 2020

NIDDK Funding Opportunity Application Due Date: Biomarkers of Dietary Intake and Exposure Coordinating Center (U24 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites cooperative agreement applications under the U24 mechanism, for a Data Coordinating Center (DCC) to participate in a consortium and coordinate the activities of Dietary Biomarker Development Centers program (DBDC). A companion FOA (RFA-DK-20-005), (U2C Clinical Trial Required) invites applications from multidisciplinary teams, for establishing Dietary Biomarkers Development Centers (DBDCs), to discover, develop, and validate dietary biomarkers of intake and exposure.

More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-007.html


Oct. 21, 2020

NIDDK Funding Opportunity Application Due Date: Development of Biomarkers of Dietary Intake and Exposure (U2C Clinical Trial Required)

The purpose of this Funding Opportunity Announcement is to invite applications from multidisciplinary teams to establish Dietary Biomarkers Development Centers that explore and develop metabolomics-based dietary intake biomarkers.

Oct. 26, 2020

ADA Funding Opportunity Application Due Date: The American Diabetes Association Cardiovascular-Metabolic Fellowship Awards

The American Diabetes Association (ADA) Cardiovascular-Metabolic Fellowship Awards are designed to support basic, clinical or translational research focused on cardiovascular disease in the context of diabetes. Applications from postdoctoral research fellows proposing fundamental biological research, mechanistic and outcome-based clinical studies, behavioral research, and epidemiologic research will be accepted.

Abstract Submission Deadline: NIDDK Network of Minority Health Research Investigators(NMRI) Virtual West Regional Meeting

More than 300 researchers have participated in NMRI workshops in the past decade, and approximately 100 are active members. The success of the NMRI, a network that is “owned” by its members and supported by the NIDDK, begins with the dedication of senior investigators who mentor and serve as role models for junior investigators. The participation of active members and the recruitment of new members is a primary reason for the Network’s success in the past and the reason for confidence that it will continue to grow in the future. Registration Deadline: November 2nd, 2020. Event Date: December 7th, 2020

More information:

https://www.niddk.nih.gov/news/meetings-workshops/2020/nmri-virtual-west-regional-meeting

Oct. 28, 2020

Advancing Basic and Translational Research for Genitourinary Conditions: Female Urethral Function and Failure Weekly Session 5

Session 5—The Urethra: Technologies for Translation. Enormous knowledge gaps exist in our understanding of the function and dysfunction of the lower urinary tract. To fill these gaps, we are pioneering a virtual workshop series composed of seven weekly sessions. These sessions will convene a multiperspective brain trust, including basic, translational, and clinical researchers at all stages of their careers; health professionals; patients; and industry representatives.

More information:

https://www.niddk.nih.gov/news/meetings-workshops/2020/Advancing-Basic-Translational-Research-Benign-Genitourinary-Conditions-Female-Urethra

Oct. 29, 2020

Abstract Submission Due Date: ENDO 2021

ENDO 2021 will take place virtually March 20-23, 2021 using a dynamic and interactive virtual platform. By submitting your abstract, you are taking the first step on a journey that benefits your career as well as the larger scientific and medical community.

More information:

https://www.endocrine.org/meetings-and-events/endo2021/endo-2021-abstract-submissions

Oct. 30, 2020

HIRN Funding Opportunity Application Due Date: HIRN EMERGING LEADERS IN T1D (2020)

The Human Islet Research Network (HIRN) is announcing a new competitive funding initiative (HIRN Emerging Leaders in T1D) to provide support and protected time for senior postdoctoral fellows seeking to pursue studies that will enhance their transition toward independent research careers. Applications are sought from experienced postdoctoral fellows with a minimum of two years of ongoing postdoctoral experience who intend to continue research careers in scientific areas supported by the Human Islet Research Network. This opportunity is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial that is itself comprised of a clinical trial intervention.

More information: https://hirnetwork.org/emergingleaders2020



Search

Recent dkNET Blog

dkNET Office Hours: NIH Data Management and Sharing Mandate

dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data and Workflow-Based Analyses"

dkNET community events and announcements in April, 2024

dkNET Blog Tags

About

The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant 2U24DK097771-09.

Recent News Entries

dkNET Office Hours: NIH Data Management and Sharing Mandate

Join HIRN Webinar: Emerging Role for Tissue-Specific Extracellular Vesicles in Disease Diagnosis: Implications for T1D on April 23

dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data and Workflow-Based Analyses"

Contact Us

Email: info_at_ dknet.org

Stay Connected

About SciCrunch | Privacy Policy | Terms of Service

SciCrunch
X

Are you sure you want to delete that component?